Professor
Fred Hutchinson Cancer Center
Disclosure: AlloVir (Consultant)EvrysBio (Advisor or Review Panel member, Other Financial or Material Support, share options)Gilead (Consultant, Grant/Research Support)GSK (Consultant)Helocyte (Advisor or Review Panel member, Shareholder)Lophius (Grant/Research Support)Merck (Consultant, Grant/Research Support)SymBio (Consultant)VirBio (Consultant, Grant/Research Support)
Michael Boeckh, MD, PhD, is the Head of the Infectious Disease Sciences Program and Professor in the Vaccine and Infectious Disease and Clinical Research Divisions at Fred Hutchinson Cancer Center, and a Professor of Medicine, Division of Allergy and Infectious Diseases, at the University of Washington. He received his MD and PhD degrees from the Freie Universität Berlin, Germany, and trained in internal medicine at the Benjamin Franklin Hospital in Berlin, Germany, and in infectious diseases at the University of Washington. He is an expert in viral infections in the immunocompromised host. Dr. Boeckh is a Fellow of the Infectious Disease Society of America and elected Member of the Association of American Physicians . He conducts laboratory research, observational studies as well as clinical trials of all phases, and has authored more than 300 peer-reviewed articles, review articles, practice guidelines and book chapters. His two key scientific areas of research are CMV and respiratory viruses, with an emphasis on laboratory based mechanistic studies on immunologic control of viral acquisition and the pathogenesis of progressive infection and long-term pulmonary disease associated with respiratory viruses, including its most severe manifestation of bronchiolitis obliterans. Recently, his research has extended to COVID-19, including natural history studies to and interventional trials.
